|
LA JOLLA PHARMACEUTICAL CO - 10-Q - 20040507 - SIGNATURES
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
|
|
|
|
|
|
|
|
La Jolla Pharmaceutical Company
|
|
|
Date: May 7, 2004
|
/s/ Steven B. Engle
|
|
|
|
Steven B. Engle
|
|
|
|
Chairman and Chief Executive Officer
(On behalf of the Registrant)
|
|
|
|
|
|
|
|
|
|
/s/ Gail A. Sloan
|
|
|
|
Gail A. Sloan
|
|
|
|
Vice President of Finance, Controller and Secretary
(As Principal Financial and Accounting Officer)
|
|
16
LA JOLLA PHARMACEUTICAL COMPANY
INDEX TO EXHIBITS
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
10.53
|
|
Supplement to employment offer letter for Gail Sloan
|
|
|
|
|
|
10.54
|
|
Promissory Note, dated as of March 31, 2004, between the Company and
General Electric Capital Corporation
|
|
|
|
|
|
31.1
|
|
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
31.2
|
|
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
32.1
|
|
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
Next Section
Previous Section